In this Section |
256706 Elevated Lung Cancer Mortality Among Uranium Gaseous Diffusion Plant Workers: A Nested Case-Control DesignSunday, October 28, 2012
BACKGROUND. Several cancer mortality risk studies among uranium gaseous diffusion workers have failed to show elevated lung cancer risk.
OBJECTIVE: Assess lung cancer mortality risk among uranium gaseous diffusion workers at the Gaseous Diffusion Plant in Paducah, KY. METHODS: Population: A cohort of 6,820 uranium gaseous diffusion workers was selected. Eligible workers worked more than six months from 1952 to 2002. There were 1,672 deaths, 696 cancer deaths, and 143 lung cancer deaths. Case/Control Definition: Lung cancer deaths were identified ICD codes 6 thru 10 appearing as the underlying cause of death on the death certificate. Controls were all other cohort members regardless of vital status. Exposure Assessment: External radiation exposure was assessed by external badge monitor data. Other toxic exposures (As, Be, Cr, Ni, U, & trichloroethyle) were assessed by a job-specific job-exposure-matrix. Tobacco smoking was assessed using sensitivity analysis. Data Analysis: STATA (Version 10.1) was used to compute descriptive and analytic statistics. RESULTS: Lung cancer mortality risk among uranium gaseous diffusion workers was elevated approximately two fold (OR = 1.7; 95% CI 1.21, 2.31) and was primarly associated with nickel, uranium, and external radiation exposures as well as duration of employment. Tobacco smoking accounted for nearly twenty percent decrease in the cude mortality risk associated uranium,or nickel exposure. CONCLUSION: Lung cancer mortality risk was elevated among uranium gaseous diffusion workers employed between 1952 and 2002 at the Paducah Gaseous Diffusion Plant.
Learning Areas:
Chronic disease management and preventionEnvironmental health sciences Epidemiology Occupational health and safety Public health or related organizational policy, standards, or other guidelines Learning Objectives: Keywords: Occupational Health, Cancer Prevention
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: Dr. Figgs published (IJOEM, 2011) an assessment of suicide risk in this same cohort. As co-investigator, Dr. Figgs has permission and a responsibility to publish the findings. All participating IRBs (NIOSH, University of Cincinnati, University of Louisville, & University of Kentucky approved the study protocol and data collection. Dr. Figgs has no current interest conflicts, nor past financial, religious, academic, personal, and/or philosophical interest conflicts regarding the information to be presented in this abstract. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 2048.0: Poster Session: Chemicals and Toxic Substances
|